3-(4-(2-(3-(4-Chlorophenyl)-1,2,4-oxadiazol-5-yl)-2-(4-methoxyphenyl)ethyl)phenyl)isoxazole-5-carboxylic acid, 95%, 50mg

Achromatic S60x/0.85 objective. Parafocal 35 mm

N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-3H-purin-2-yl)isobutyramide, 97%, 10g

1,6-Heptadiyne, 98.0%, 1g

2,3-Dimethylbutanoic acid, 95.0%, 1g

1-Boc-4-(2-Methoxyethylamino)piperidine, 95.0%, 5g

N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine, 95.0%, 25g

METHYL 2-((TERT-BUTOXYCARBONYL)AMINO)-2-(OXETAN-3-YL)ACETATE, 95.0%, 10g

(3-Methoxy-2-methylphenyl)boronic acid, 95.0%, 10g

Cyclopentylsulfonyl chloride, 95.0%, 1g

Benzo[cd]indol-2(1H)-one>97.0%(HPLC)(N)5g

Fmoc-3-(2-Naphthyl)-L-alanine, 98.00%, 5g

3-Bromo-8-methylimidazo[1,2-a]pyridine-2-carbaldehyde, 95.0%, 1g